A male contraceptive pill could enter human trials in just two months after tests on mice were successful. The pill, which is non-hormonal, blocked 99 percent of pregnancies in mice at trial stage, reports Vice.
It means the male contraceptive, medically named YCT529, is now on par with the female birth control medication. Researchers at the University of Minnesota, who invented the drug, say it could enter clinical trials as early as July this year.
The pill does not target testosterone, the male sex hormone, cutting the risk of side effects which have kept the drugs landing in pharmacies. Crucially, trials also found male mice were able to father pups four to six weeks after taking it.
